Intrinsic Value of S&P & Nasdaq Contact Us

Immutep Limited IMMP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • AU • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.25
+681.3%

Immutep Limited (IMMP) reported total assets of $147.2M and total liabilities of $48.3M for quarter ending 2025-12-31, resulting in total equity of $98.9M.

The company held $99.13M in cash and short-term investments. Total debt stood at $1.21M, with net debt of $-71.54M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 2.97, indicating strong short-term liquidity. Interest coverage is -2430.1x (weak).

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.01, current ratio of 2.97, interest coverage -2430.1x — balance sheet is strong
  • MOAT (0/100) — Total assets $147.2M and equity $98.9M support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 0.01 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 47/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Immutep Limited Balance Sheet History
Metric Q2 FY2026 Q4 FY2025 Q2 FY2025 Q4 FY2024
Total Assets $147.2M$156.98M$182.33M$201.58M
Total Liabilities $48.3M$13.35M$9.86M$12.06M
Total Debt $1.21M$1.63M$1.68M$1.59M
Cash & Investments $99.13M$129.69M$159.26M$181.88M
Total Stockholders Equity $98.9M$143.64M$172.47M$189.52M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message